SPDR S&P Biotech ETF (XBI) Stock Price, News, Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US ETFDetailed Quotes

XBI SPDR S&P Biotech ETF

Watchlist

89.495
-2.815-3.05%

Trading Jan 10 11:03 ET

90.590High89.120Low

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Gilead Sciences Analyst Ratings
BenzingaJan 10 06:29 ET · Ratings
Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Seeking AlphaJan 9 15:36 ET
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
BenzingaJan 9 14:12 ET
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report
Seeking AlphaJan 9 11:35 ET
Peering Into Biogen's Recent Short Interest
BenzingaJan 9 11:00 ET
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
Seeking AlphaJan 9 08:56 ET

Comments

Kim10

Jan 8 16:20

$SPDR S&P Biotech ETF (XBI.US)$ big bearish flow coming in looking like a hedge. Potential put play, small size.

topcing

Nov 4, 2024 21:29

$SPDR S&P Biotech ETF (XBI.US)$ yea

股勇者

Oct 25, 2024 10:17

$SPDR S&P Biotech ETF (XBI.US)$ 100 month end? ok?

Bellaah

Sep 11, 2024 11:10

$SPDR S&P Biotech ETF (XBI.US)$ 95

Moomoo Learn

Sep 6, 2024 03:05

Columns Navigating the wave of lower interest rates

Given the strong market expectations for a Federal Reserve rate cut, as indicated by the CME data with a 57% chance for a 25-basis-point reduction and a 43% chance for a 50-basis-point cut in September, investors are poised to reconsider their strategies.
With the Fed's September meeting likely to deliver a rate decrease, the question arises: how should investors allocate assets during an interest rate cut cycle? Let's delve into the tactics and consid...

CPI hits 3-year low: How will it sway the Fed rate decision?